secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2021-12-13T23:59:59+00:00
Accession:  0001628280-21-024959
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex appoints Gary Ng to Board, replaces Tony Lau as Champion River nominee
--------------------------------------------------------------------------------

- Gary Ng appointed to Board effective Dec 13, 2021, to serve until 2022 annual meeting.
- Ng replaces Tony Lau (resigned Nov 2, 2021) as Champion River Ventures' nominee under Purchase Agreement.
- Ng receives $40k annual retainer, $7.5k for Compensation Committee, initial option for 40k shares vesting over 3 years.
- Ng is Project Director at Horizon Ventures, which is affiliated with Champion River.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828021024959/0001628280-21-024959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828021024959/cdxc-20211213.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-024959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer